296 related articles for article (PubMed ID: 28338236)
41. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
Zhao G; Li CX; Guo C; Zhu H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
43. [Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
Zhang HM; Yang B; Chen HF; Chi XH; Xi YB; Chen XM; Guo B; He PF; Lu XC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jun; 34(6):530-535. PubMed ID: 31032588
[TBL] [Abstract][Full Text] [Related]
44. Identification of potential biomarkers associated with immune infiltration in papillary renal cell carcinoma.
Deng R; Li J; Zhao H; Zou Z; Man J; Cao J; Yang L
J Clin Lab Anal; 2021 Nov; 35(11):e24022. PubMed ID: 34606125
[TBL] [Abstract][Full Text] [Related]
45. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
Ruan L; Xie Y; Liu F; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
[TBL] [Abstract][Full Text] [Related]
46. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X
Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of Hsa-miR-320 Is Associated With Invasion and Metastasis of Ovarian Cancer.
Wang W; Yang J; Xiang YY; Pi J; Bian J
J Cell Biochem; 2017 Nov; 118(11):3654-3661. PubMed ID: 28338235
[TBL] [Abstract][Full Text] [Related]
48. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.
Dong R; Shen Z; Zheng C; Chen G; Zheng S
Sci Rep; 2016 Feb; 6():21084. PubMed ID: 26879603
[TBL] [Abstract][Full Text] [Related]
49. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
50. Key miRNAs and target genes played roles in the development of clear cell renal cell carcinoma.
Liu J; Liu B; Guo Y; Chen Z; Sun W; Gao W; Wu H; Wang Y
Cancer Biomark; 2018; 23(2):279-290. PubMed ID: 30198869
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma.
Xin G; Cao X; Zhao W; Lv P; Qiu G; Li Y; Wang B; Fang B; Jia Y
Math Biosci Eng; 2020 Nov; 17(6):8074-8083. PubMed ID: 33378933
[TBL] [Abstract][Full Text] [Related]
52. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Wang ZX; Deng TX; Ma Z
J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
[TBL] [Abstract][Full Text] [Related]
53. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
54. Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression.
Li J; Liang L; Xiu L; Zeng J; Zhu Y; An J; Wu L
Ann Transl Med; 2022 Jan; 10(2):125. PubMed ID: 35282101
[TBL] [Abstract][Full Text] [Related]
55. [Exploratory screening of potential pan-cancer biomarkers based on The Cancer Genome Atlas database].
Zhou C; Ma X; Xing YK; Li LD; Chen J; Yao BY; Fu JL; Zhao P
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):602-607. PubMed ID: 34145869
[TBL] [Abstract][Full Text] [Related]
56. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
[TBL] [Abstract][Full Text] [Related]
57. FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma.
Tsimafeyeu I; Khasanova A; Stepanova E; Gordiev M; Khochenkov D; Naumova A; Varlamov I; Snegovoy A; Demidov L
Clin Transl Oncol; 2017 Feb; 19(2):265-268. PubMed ID: 27379982
[TBL] [Abstract][Full Text] [Related]
58. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation.
Feng X; Zhang M; Meng J; Wang Y; Liu Y; Liang C; Fan S
Oncol Res; 2020 May; 28(3):285-297. PubMed ID: 31948514
[TBL] [Abstract][Full Text] [Related]
59. Deciphering a Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma.
Bao JH; Li JB; Lin HS; Zhang WJ; Guo BY; Li JJ; Fu LM; Sun YP
Anal Cell Pathol (Amst); 2022; 2022():2721005. PubMed ID: 35509814
[TBL] [Abstract][Full Text] [Related]
60. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
